TransMedics Group, Inc. Forecasted to Post Q2 2024 Earnings of $0.10 Per Share (NASDAQ:TMDX)
Related Articles
-
Q2 2024 EPS Estimates for Viper Energy, Inc. Decreased by Analyst (NASDAQ:VNOM)
Viper Energy, Inc. (NASDAQ:VNOM – Free Report) – Equities research analysts at Roth Capital decreased their Q2 2024 earnings per share estimates for shares of Viper Energy in a note issued to investors on Wednesday, May 1st. Roth Capital analyst L. Mariani now expects that the oil and gas producer will post earnings of $0.31 […]
-
Lexeo Therapeutics, Inc.’s Lock-Up Period Set To End on May 1st (NASDAQ:LXEO)
Lexeo Therapeutics’ (NASDAQ:LXEO – Get Free Report) lock-up period is set to expire on Wednesday, May 1st. Lexeo Therapeutics had issued 9,090,910 shares in its public offering on November 3rd. The total size of the offering was $100,000,010 based on an initial share price of $11.00. After the end of the company’s lock-up period, major […]
-
MCF Advisors LLC Purchases 204,170 Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX)
MCF Advisors LLC boosted its position in Poseida Therapeutics, Inc. (NASDAQ:PSTX – Free Report) by 476.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 247,024 shares of the company’s stock after buying an additional 204,170 shares during the quarter. MCF Advisors LLC’s holdings in Poseida Therapeutics were worth $830,000 as of its most […]